Press Releases 2017-05-26T02:38:45+00:00

Press Releases

August 9: New Paper Captures Pain, Suffering, and Anxiety Inflicted on Patients with Cancer by Pharmacy Benefit Managers

Community Oncology Alliance Releases Fourth in Series of True Patient-PBM Horror Stories Today, the Community Oncology Alliance (COA) continues to expose the inhumane pain, suffering, and anxiety inflicted by Pharmacy Benefit Managers (PBMs) on patients with cancer with the release of another paper documenting real-life PBM horror stories. Telling the [...]

July 17: Community Oncology Alliance Submits Formal Comments on President’s Blueprint to Reduce Drug Prices

COA Applauds Administration for Taking Bold Action to Address High Drug Prices, Cautions Against Misguided Policy Changes that Would Negatively Impact Cancer Patients  The Community Oncology Alliance (COA) formally submitted comments to the Health and Human Services (HHS) Secretary Alex Azar regarding President Trump’s “Blueprint to Lower Drug Prices and [...]

July 2: COA Supports 340B Drug Discount Accountability Act

HR 6240 Will Provide HRSA With Proper Funding for Program Oversight and Fulfill Longstanding Bipartisan Proposal The Community Oncology Alliance (COA) supports the introduction of the “340B Drug Discount Accountability Act” (HR 6240) by Representative Chris Collins (R-NY). This legislation will ensure that the Health Resources and Services Administration (HRSA) [...]

May 25: Community Oncology Alliance Supports Bipartisan “Phair Pricing” PBM Reform Act – Ensuring Patients Receive All Negotiated Discounts and Rebates at Point-of-Sale is Important Step to Reforming Broken Drug Pricing System

The Community Oncology Alliance (COA) strongly supports H.R. 5958, the “The Phair Pricing Act of 2018” introduced today by Representatives Doug Collins (R-Ga.) and Vicente Gonzalez (D-Texas). This bipartisan bill will ensure that the savings that pharmacy benefit managers (PBMs) negotiate are passed along to patients at the point-of-sale. Under [...]

April 24: COA STATEMENT ON 340B OPTIMIZATION ACT

“Years of independent studies and investigations have uncovered that the 340B program is out of control in many hospitals and is not functioning to help patients in need. As Congress examines the 340B program and develops legislative solutions to fix 340B, it is critical that policymakers have the facts about [...]

April 12: COA Releases 2018 Practice Impact Report: 1,653 Clinics and/or Practices Closed, Acquired, Merged, or Struggling

COA Practice Impact Report Details Consolidation, Shift of U.S. Cancer Care System Into More Expensive Hospital Setting Community Oncology Alliance (COA) Practice Impact Report Data Shows 1,653 Clinics and/or Practices Have Closed, Been Acquired by Hospitals, Merged, or Reported Financial Struggles Since 2008 Misguided Public Policies of 340B and Sequester [...]

April 12: Cancer Care Teams and Advocates Gather in Washington for Largest Community Oncology Conference Ever

“Keeping Patients at Center” Theme Reflected Across 2018 COA Conference Business, Clinical, Pharmacy, and Advocacy Tracks Keynote Speakers at 16th Annual Conference Include U.S. FDA Commissioner Scott Gottlieb, MD and NY Giants Linebacker Mark Herzlich The Community Oncology Alliance (COA) kicks off the 2018 Community Oncology Conference today, gathering nearly [...]

April 11: Patients: Doctors and Patients, Not Pharmacy Benefit Managers, Should Make Cancer Care Decisions

Nearly 100 advocates from 22 community oncology practices in 14 states warn Congress that pharmacy benefit managers jeopardize cancer care, demand lawmakers keep patients and doctors at the center  Washington, DC—Nearly 100 cancer care advocates are on Capitol Hill this week to urge Congress to introduce more transparency and accountability [...]

February 23: COA: Analysis Shows Massachusetts Hospitals Benefit From Recent Changes in Medicare Payment

All Massachusetts Hospitals Will See Nearly $53 Million More in Payments from Recent Increases in Medicare Part B Reimbursement and 340B Program Changes Hospitals in Massachusetts, especially those in rural areas, will benefit from recent changes to Medicare payments, including changes to reimbursement of prescription drugs under a federal program [...]

February 22: Community Oncology Alliance Names Dr. Frederick M. Schnell to Newly Created Medical Director Position

Experienced Community Oncologist Will Provide Valuable Guidance on Patient Care and Practice Operations The Community Oncology Alliance (COA) announced today that Frederick M. Schnell, M.D., F.A.C.P., has been appointed to the newly created staff position of Medical Director. He brings more than three decades of experience as a physician and [...]

February 13: Community Oncology Alliance Statement on White House Budget Proposal Drug Price Recommendations

Administration’s Budget has Numerous Smart, Overdue Policy Solutions; but Certain Medicare Part B Proposals Ignore History and will Backfire Today, the Community Oncology Alliance (COA) released the following statement regarding the White House’s proposed budget recommendations and a recent report from President Trump’s Council of Economic Advisors on strategies to [...]

January 29: New Study Shows Rural Hospitals Benefit Most From Recent 340B and Other Medicare Payment Changes, With Majority Seeing 2.7 Percent Average Payment Increases

Majority of All Hospitals Will See Average of 1.5 Percent Net Medicare Payment Increases in 2018, Offsetting 340B Payment Change Avalere Study, Commissioned by Community Oncology Alliance, Adds to Growing Body of Evidence Showing Need for Transparency in Hospital Programs 85 percent of hospitals will see net payment increases [...]

January 25: COA Statement on Alex Azar as HHS Secretary

Community Oncology Alliance Looks Forward to Working Closely with HHS Secretary Alex Azar to Strengthen and Improve the American Cancer Care System On behalf of the Board of Directors of the Community Oncology Alliance (COA), I want to congratulate and express our strong support for Alex Michael Azar II on [...]

January 17: Community Oncology Alliance Strongly Supports 340B HELP ACT

“Helping Ensure Low-income Patients have Access to Care and Treatment” Will Ensure Patients Benefit from Important 340B Program, Not Hospital Profits COA Thanks Senator Cassidy for Leadership Reforming 340B Program to Benefit Patients Washington, DC – January 17, 2018 – The Community Oncology Alliance (COA) applauds Senator Bill Cassidy (R-LA) on his leadership to improve transparency [...]

October 24: COA Hosts Seventh Summit on Oncology Payment Reform

Providers, Payers, Employers, Policymakers, and Industry Leaders Discuss Efforts to Reform Nation’s Cancer Care Payment System The Community Oncology Alliance (COA) is hosting more than 200 providers, payers, employers, policymakers, and industry leaders this week at the seventh Payer Exchange Summit on Oncology Payment Reform to discuss how they can [...]

September 28: New Study Finds Hospital Cancer Care Much More Expensive

New Study Determines Cancer Care Delivered In Hospital Outpatient Setting Much More Expensive Than In Independent, Community Oncology Practices Chemotherapy 71% More Expensive, Physician Visits 333% More Expensive, and Patients Have Higher Rates of Emergency Department Visits When Treated in Hospital Outpatient Setting Data Consistent Across Tumor Types, Including Breast, [...]

September 19: New White Paper Details Bureaucracy, Deadly Delays, and Apathy by Pharmacy Benefit Managers – COA White Paper Continues to Share True Patient-PBM Stories and How They Hurt Cancer Patients

Today, the Community Oncology Alliance (COA) and the Community Oncology Pharmacy Association (COPA) released a new white paper sharing more real patient stories detailing the negative impact pharmacy benefit managers (PBMs) have on cancer care. Compiling stories from cancer patients and physicians, the white paper “Bureaucracy, Deadly Delays, and Apathy: [...]

September 14: COA Representatives Join Congressional Briefing on Personalized Medicine and the Future of Cancer Care Delivery and Payment

Representatives from the Community Oncology Alliance (COA) joined other cancer stakeholders and policymakers on Capitol Hill today for a briefing on personalized medicine and the future of cancer care delivery and payment. The briefing was moderated by COA Executive Director Ted Okon, and featured COA Executive Committee Member Kashyap Patel, [...]

July 17: CMS Proposal a Huge Step in the Right Direction to Curbing 340B Hospital Abuses, Stopping Cancer System Consolidation, and Reducing Costs for Seniors

The Community Oncology Alliance (COA) applauds the Centers for Medicare & Medicaid Services (CMS) for its proposals to address abuses of the 340B Drug Discount Program and move to parity payments for medical services, regardless of the site of care. These changes will result in significant cost savings for our [...]

June 6: Congress Must Reject Changes to Medicare Part B

This week the Community Oncology Alliance (COA) is launching a major inside-the-beltway campaign to let Congress know that it must reject changes to Medicare Part B. The government is proposing changes to Medicare with funding cuts which will impact the care vulnerable seniors receive from their doctors under the [...]

June 2: New COA White Paper “Unaccountable Benefit Managers” Shines Light On How Pharmacy Benefit Managers Hurt Cancer Patient Care

 Second in White Paper Series Compiling True Patient-PBM Stories; Accompanies New Website PBMAbuses.Com    A new white paper released today by the Community Oncology Alliance (COA) and the Community Oncology Pharmacy Association (COPA) continues to shine a light on the negative impact pharmacy benefit managers (PBMs) have on the care [...]

April 27: COA White Paper Exposes Delay, Waste, and Cancer Treatment Obstacles Imposed on Patients by Pharmacy Benefit Managers

Compilation of True Patient-PBM Stories Released and Discussed at 2017 Community Oncology Conference A new white paper released today by the Community Oncology Alliance (COA) and the Community Oncology Pharmacy Association (COPA) exposes the negative impact pharmacy benefit managers (PBMs) have on the care cancer patients receive. Compiling real stories [...]

April 27: 2017 Community Oncology Conference, “Fueling the Cancer Moonshot” Brings Together Pioneering Cancer Care Teams

2017 Community Oncology Conference, “Fueling the Cancer Moonshot” Brings Together Pioneering Cancer Care Teams Physicians, Administrators, Nurses, Pharmacists, and Patient Advocates Will Share Latest Innovation in Cancer Care Today, the Community Oncology Alliance (COA) kicks off the 2017 Community Oncology Conference, the theme of which this year is “Fueling the [...]

April 26: Community Oncology Advocates Head to Capitol Hill

Community Oncology Advocates Head to Capitol Hill In Support of Local Cancer Care More than 380 local cancer treatment practices have closed since 2008, forcing patients and their families to routinely travel farther for the care they need Cancer care advocates from Community Oncology Alliance (COA) Patient Advocacy Network, or [...]

March 6: Community Oncology Alliance Endorses Congressman Collins’ Prescription Drug Price Transparency Act

Community Oncology Alliance Endorses Congressman Collins’ Prescription Drug Price Transparency Act Greater transparency and accountability from pharmacy benefit managers (PBMs) will lower costs for patients and taxpayers The Community Oncology Alliance (COA) endorses the Prescription Drug Price Transparency Act (H.R. 1316) and thanks Congressman Doug Collins (R-GA) and the bill’s [...]

March 2: Community Oncology Alliance Applauds New Oncology Payment Reform Bill by U.S. Senators Cornyn and Carper

Oncology Medical Home Model Demonstration Project Will Support Quality and Value in Cancer Care The Community Oncology Alliance (COA) commends United States Senators John Cornyn (R-TX) and Tom Carper (D-DE) for introducing the Cancer Care Payment Reform Act of 2017 (S.463) which establishes a national Oncology Medical Home (OMH) demonstration [...]

February 8: COA State of Community Oncology and 2017 Priorities

COA Hosts “State of the Union” Luncheon for Advocates, Stakeholders, and Industry Leaders Today, the Community Oncology Alliance (COA) hosted a “State of the Union” briefing on the state of community oncology at the National Press Club in Washington, DC. More than 100 representatives of national cancer care, patient advocacy, [...]

November 22: Breaking News: Medicare Part B Experiment Dead

The Community Oncology Alliance (COA) believes that, for all intents and purposes, the Medicare Part B experiment (demo) on cancer care is dead. Late last week, top Democrats, including incoming Senate Minority Leader Chuck Schumer and House Minority Leader Nancy Pelosi, requested that the Obama administration not release the final [...]

September 8: Hematology-Oncology Associates of Central New York Launches CPAN Chapter

Patients and Physicians at Hematology-Oncology Associates of Central New York launch National Cancer Advocacy Group Chapter COA Patient Advocacy Network (CPAN) Chapter to Advocate for Local, Accessible, and Affordable Cancer Care for All in New York East Syracuse residents have a new group dedicated to advocating for local, accessible, and affordable cancer care in their [...]

July 28: COA Launches Advanced Practice Provider Network

Learning Network for Nurse Practitioners, Physician Assistants, and Other Advanced Practice Providers in Oncology COA has launched a new initiative to support advanced practice providers in oncology. Called the Advanced Practice Provider Network or “CAPP Network,” the initiative will support oncology nurse practitioners, physician assistants, and other advanced practice providers who [...]

COA Submits Formal Comments on CMS Medicare Part B “Model”

COA Submits Formal Comments on CMS Medicare Part B “Model” It is an Experiment that is Bad Medicine, Flawed Economics, Destructive Policy, and Legally Invalid The Community Oncology Alliance (COA) today submitted formal comments to the Centers for Medicare & Medicaid Services (CMS) regarding the proposed Medicare Part B Drug [...]

Landmark Study Takes In-Depth Look at Cost Drivers of Cancer Care

New Milliman Study Commissioned by Community Oncology Alliance Finds Costs for Treating Patients With Cancer Increased at Essentially Same Rate as Other Health Care Spending Findings Examine Impact of Drug Payments and Disparate Site of Service Costs A new Milliman study shows that over the last decade the total costs of [...]

316 of Nation’s Leading Health Care and Patient Advocacy Groups Implore Congress to Oppose Medicare’s Experiment

Groups warn proposed Medicare Part B Drug Payment Model will adversely affect the care and treatment of Medicare patients with complex conditions WASHINGTON, March 17, 2016 /PRNewswire-USNewswire/ -- Today, 316 leading healthcare and patient advocacy organizations sent a letter to Senate Majority Leader Mitch McConnell, Senate Minority Leader Harry Reid, [...]

Community Oncology Alliance Patient Survey Reaches Landmark In Measuring Quality And Value In Cancer Care

Oncology Medical Home Initiative Reaches 50,000 Patient Surveys Completed as Criteria for Quality of Care Improvement and Payment Reform WASHINGTON, D.C. – July 27, 2015 – The Community Oncology Alliance (COA), a not-for-profit organization dedicated to preserving access to community cancer care, announced today that cancer patients have completed 50,000 [...]

COA Kicks Off Community Oncology Conferences; Announces Major White Paper

A Detailed Diagnosis of Integrated Community Oncology is a comprehensive study of the value provided and challenges faced by integrated community oncology practices, the foundation of the nation’s cancer care delivery system. The COA-sponsored study, the work of Berkeley Research Group (BRG) researchers Aaron Vandervelde and JoAnna Younts, included the [...]

COA Community Oncology Pharmacy Association Names Board Co-Chairs

COA and the Community Oncology Pharmacy Association (COPA) announced the appointment of COPA co-chairs, Joshua Cox, Pharm. D. and Thomas Harwood, CPT. Joshua Cox, Pharm. D., BCPS, director of pharmacy, Dayton Physicians Network, Dayton, Ohio, and Thomas Harwood, CPT, deputy director of clinical operations, NSHOA Cancer Center, East Setauket, N.Y., [...]

Community Oncology Alliance Announces Support Of Bill To Help Stabilize The Nation’s Deteriorating Cancer Care Delivery System

Proposed Bill Will Correct CMS' Inappropriate Application of the Sequester Cut To Payments for Cancer Drugs WASHINGTON, March 19, 2015 /PRNewswire/ -- The Community Oncology Alliance (COA), a not-for-profit organization dedicated to preserving access to community cancer care, announced its vigorous support of the Cancer Patient Protection Act of 2015 [...]

Community Oncology Alliance Announces Launch Of National Organization Focused On Oral Cancer Drugs

Commercial Interests Threaten to Interfere with Critical Physician-Patient Bond Essential to Quality Cancer Care WASHINGTON, D.C. – March 17, 2015 – The Community Oncology Alliance (COA), a not-for-profit organization dedicated to preserving access to community cancer care, announced today the formation of the Community Oncology Pharmacy Association (COPA). COPA is [...]